Accolade Inc (STU:4NE1)
€ 3.42 0.12 (3.64%) Market Cap: 275.12 Mil Enterprise Value: 279.28 Mil PE Ratio: 0 PB Ratio: 0.70 GF Score: 61/100

Accolade Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 11, 2020 / 03:15PM GMT
Jailendra P. Singh;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

All right. Hello, everyone. I'm Jailendra Singh, health care technology and distribution analyst at Credit Suisse. Thanks, everyone, for joining us this afternoon -- actually, this morning. So next up, we have Accolade. From the company, we have Raj Singh, CEO; Steve Barnes, CFO; and Todd Friedman, Senior VP of IR.

By way of background, Accolade is a personalized health and benefit solution platform, which engages the entire member population and helps them navigate the health care continuum. Rajeev -- Raj joined Accolade in 2015 as a Board member, investor and CEO. Steve joined Accolade in 2015 as CFO. Raj and Steve will begin with a quick 20-minute presentation. We will then open the line for Q&A. With that, Raj, over to you.

Rajeev Singh
Accolade, Inc. - CEO & Executive Director

Thank you, Jailendra, and I appreciate all of you being here and digging into the Accolade story. Todd, if you could pull the presentation up, we'll run you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot